Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 4,703 | 4,782 | 4,824 | 4,710 | 4,663 |
| Gross Profit | 4,703 | 4,782 | 4,824 | 4,710 | 4,663 |
| Operating Expenses | 12,113 | 10,180 | 8,687 | 10,781 | 9,786 |
| Operating Income | -7,410 | -5,398 | -3,863 | -6,071 | -5,123 |
| Other Income | 9 | 3 | -12 | 162 | -24 |
| Pre-tax Income | -7,401 | -5,395 | -3,875 | -5,909 | -5,147 |
| Net Income Continuous | -7,401 | -5,395 | -3,875 | -5,909 | -5,147 |
| Net Income | $-7,401 | $-5,395 | $-3,875 | $-5,909 | $-5,147 |
| EPS Basic Total Ops | -0.40 | -5.38 | -3.93 | -6.05 | -5.27 |
| EPS Basic Continuous Ops | -0.40 | -5.38 | -3.93 | -6.05 | -5.27 |
| EPS Diluted Total Ops | -0.40 | -5.38 | -3.93 | -6.05 | -5.27 |
| EPS Diluted Continuous Ops | -0.40 | -5.38 | -3.93 | -6.05 | -5.27 |
| EBITDA(a) | $-7,243 | $-5,210 | $-3,636 | $-5,836 | $-4,891 |